Rapport Therapeutics, Inc.
RAPP
$10.17
-$0.30-2.87%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
5/10/2025
-
TipRanks Financial Blog
5/8/2025
-
Simply Wall St
5/8/2025
-
SeekingAlpha.com: All News
5/8/2025
-
GuruFocus
5/8/2025
-
The Fly
5/8/2025
-
The Fly
5/8/2025
-
Globe Newswire
5/2/2025
-
Ticker Report
4/29/2025
-
Ticker Report
4/29/2025
-
MarketBeat
4/27/2025
-
Ticker Report
4/22/2025
-
MarketBeat
4/22/2025
-
GuruFocus
4/22/2025
-
Globe Newswire
4/22/2025
-
MarketBeat
4/22/2025
-
MarketBeat
4/14/2025
-
MarketBeat
4/10/2025
-
MarketBeat
4/10/2025
-
MarketBeat
4/8/2025
-
Ticker Report
4/8/2025
-
The Fly
4/7/2025
-
ETF Channel
4/2/2025
-
Ticker Report
3/31/2025
-
SeekingAlpha
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, May 8, 2025
Period Date
Monday, March 31, 2025
Next Filing
Week of Aug 4 and 8 (est)
Price History
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
857 321 8020
Address
1325 Boylston Street
Boston, MA 02215
Boston, MA 02215
Country
Year Founded
Business Description
Sector
Rapport Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company that focuses on the discovery and development of transformational small molecule medicines for patients...
more